FCCC LOGO Faculty Publications
Abu-Rustum NR , Yashar CM , Bradley K , Campos SM , Chino J , Chon HS , Chu C , Cohn D , Crispens MA , Damast S , Diver E , Fisher CM , Frederick P , Gaffney DK , George S , Giuntoli R , Han E , Howitt B , Huh WK , Lea J , Mariani A , Mutch D , Nekhlyudov L , Podoll M , Remmenga SW , Reynolds RK , Salani R , Sisodia R , Soliman P , Tanner E , Ueda S , Urban R , Wethington SL , Wyse E , Zanotti K , McMillian NR , Motter AD
NCCN GuidelinesĀ® Insights: Uterine Neoplasms, Version 3.2021
J Natl Compr Canc Netw. 2021 Aug 1;19(8) :888-895
Back to previous list
Abstract
The NCCN Guidelines for Uterine Neoplasms provide recommendations for diagnostic workup, clinical staging, and treatment options for patients with endometrial cancer or uterine sarcoma. These NCCN Guidelines Insights focus on the recent addition of molecular profiling information to aid in accurate diagnosis, classification, and treatment of uterine sarcomas.
Notes
1540-1413 Abu-Rustum, Nadeem R Yashar, Catheryn M Bradley, Kristin Campos, Susana M Chino, Junzo Chon, Hye Sook Chu, Christina Cohn, David Crispens, Marta Ann Damast, Shari Diver, Elisabeth Fisher, Christine M Frederick, Peter Gaffney, David K George, Suzanne Giuntoli, Robert Han, Ernest Howitt, Brooke Huh, Warner K Lea, Jayanthi Mariani, Andrea Mutch, David Nekhlyudov, Larissa Podoll, Mirna Remmenga, Steven W Reynolds, R Kevin Salani, Ritu Sisodia, Rachel Soliman, Pamela Tanner, Edward Ueda, Stefanie Urban, Renata Wethington, Stephanie L Wyse, Emily Zanotti, Kristine McMillian, Nicole R Motter, Angela D Journal Article United States J Natl Compr Canc Netw. 2021 Aug 1;19(8):888-895. doi: 10.6004/jnccn.2021.0038.